Barret Kalindjian

Dr. Kalindjian is a synthetic and medicinal chemist with peptide/protein half-life extension expertise as well as vast, small- molecule drug discovery and development experience gained within numerous therapeutic areas. Dr. Kalindjian was formerly with Beecham Pharmaceuticals, CEO/Research Director at James Black Foundation Ltd and Head of Drug Discovery at Norgin.